Clear Aligners for the Treatment of Dental Malocclusion in OI
NCT04815564 is an interventional trial sponsored by Baylor College of Medicine. As of 21 Nov 2026, it is active and no longer recruiting. It studies Osteogenesis Imperfecta. The registry lists an enrollment of 57 participants at 3 sites in 2 countries. The registry lists a start date of 1 Aug 2022 and a primary completion date of 1 Aug 2027.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT04815564 |
| Status | Active not recruiting |
| Study type | Interventional trial |
| Lead sponsor | Baylor College of Medicine |
| Enrollment | 57 |
| Registered sites | 3 |
| Countries | 2 |
| Conditions | Osteogenesis Imperfecta |
| Start | 1 Aug 2022 |
| Primary completion | 1 Aug 2027 |
| Study completion | 1 Dec 2027 |
| Last update posted | 18 Aug 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Deborah Krakow
University of California, Los Angeles
Principal Investigator - Janice Lee
NIDCR/NIH
Principal Investigator - Jean-Marc Retrouvey
Baylor College of Medicine
Principal Investigator - Julia Cohen-Levy
McGill University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California Los Angeles
Los Angeles
- Nidcr/nih
Bethesda
- Mcgill University
Montreal, Quebec
United States, by state
Outside the United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT04815564
Each answer restates registry values shown on this page.
What is NCT04815564?
NCT04815564 is an interventional trial sponsored by Baylor College of Medicine. It studies Osteogenesis Imperfecta.
Is NCT04815564 recruiting?
As of 21 Nov 2026, it is active and no longer recruiting.
Who leads NCT04815564?
The registry names Deborah Krakow (principal investigator, University of California, Los Angeles), Janice Lee (principal investigator, NIDCR/NIH), Jean-Marc Retrouvey (principal investigator, Baylor College of Medicine) and 1 more official as overall officials.
Where does NCT04815564 run?
The registry lists 3 sites in 2 countries. Most sites are in these countries: United States (2) and Canada (1).
When is NCT04815564 expected to complete?
The registry lists a primary completion date of 1 Aug 2027 and a study completion date of 1 Dec 2027. The sponsor last updated the record on 18 Aug 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.